Nearly 20% of older adults don’t plan to get flu vaccine: study
By
Lois A. Bowers
Dec 09, 2019
Nineteen percent of people aged 60 or more years do not plan to get vaccinated against influenza this year, according to a new AmeriSpeak Spotlight on Health survey from NORC at the University of Chicago.
Want to live a long life, free of dementia? Childhood stress might help
By
John O'Connor
Dec 09, 2019
Maybe traumatic childhood moments serve a useful purpose after all.
Clinical briefs for Tuesday, Dec. 10
By
John O'Connor
Dec 09, 2019
Alzheimer’s agitation treatment trials will continue … Medication helps lymphoma patients … Does marijuana use pose a cancer risk? … Physical activity good for prostate health
Time-restricted eating may benefit residents with metabolic syndrome
By
John O'Connor
Dec 06, 2019
Residents who limit their daily food intake to a 10-hour window may lose weight, lower their blood pressure and gain more stable insulin levels, a pilot study has found.
Alzheimer’s drug presentation raises hopes, concerns
By
John O'Connor
Dec 06, 2019
The reaction was decidedly mixed in San Diego when Biogen recently presented more detailed data on aducanumab.
FDA app offers help with challenging infections
By
Danielle Brown
Dec 06, 2019
Operators having trouble treating residents with challenging infectious diseases now have a new resource for reporting their experiences with breakthrough medications.
Clinical Briefs for Monday, December 9
By
John O'Connor
Dec 06, 2019
Diagnostic technique and medication may slow cognitive decline … Taming inflammation might reduce chronic disease risk … Why blood pressure may spike at night …. Blood proteins can reveal age
Regular aspirin use may reduce cancer, mortality risks
By
Alicia Lasek
Dec 05, 2019
A drug that lowers cancer and mortality risks in seniors may already be in many medicine cabinets, say cancer researchers.
Mindfulness training lowers blood pressure, fuels behavior change, study finds
By
Alicia Lasek
Dec 05, 2019
A mindfulness-based program has spurred adults to change unhealthy habits and significantly lower their blood pressure.
Promising antidepressant fails in late-stage trial
By
Alicia Lasek
Dec 05, 2019
Fast-tracked antidepressant Sage-217 failed to outperform a placebo in a stage 3 trial, according to its developer.